Target intelligence / Profile preview

Denatured and necrotic extracellular matrix and tissue proteins in burn eschar

Molecular classification
Extracellular matrix, Protein complex, Denatured proteins
01

Overview

Denatured and necrotic extracellular matrix and tissue proteins in burn eschar represent the primary pathological substrate resulting from severe thermal injury (StatPearls, 2023). This target is composed of a heterogeneous mixture of heat-damaged proteins, predominantly collagen, which have lost their structural integrity and biological function (PubMed, PMID: 31543258). The presence of this necrotic tissue, or eschar, inhibits the natural healing process by acting as a physical barrier and providing a medium for microbial colonization (NIH, 2021). In the field of burn care, these proteins are the specific targets for enzymatic debridement agents like bromelain-based concentrates (Anacaulase-bcdb) and collagenases (Collagenase clostridium histolyticum) (FDA, 2022). These drugs work by selectively cleaving the peptide bonds within the denatured proteins, effectively liquefying the eschar to facilitate its removal without damaging the underlying viable dermis (Journal of Burn Care & Research, 2019). Successful degradation of this target is critical for wound bed preparation, allowing for earlier assessment of burn depth and subsequent skin grafting or spontaneous healing (PubMed, PMID: 28430162). Therapeutic management of this target aims to reduce the surgical burden and systemic inflammatory response associated with traditional sharp debridement (Burns Journal, 2020).

Other names
Burn escharNecrotic tissueDevitalized tissueDenatured collagenNecrotic wound debris
02

Mechanism of action

Enzymatic proteolysis and hydrolysis of denatured proteins

03

Biological functions

Structural supportBarrier function
04

Disease associations

Thermal burnChronic woundPressure ulcer
05

Safety considerations

Proteolysis of viable tissuePainLocal irritationBleedingInfection risk
06

Interacting drugs

Anacaulase-bcdb

3 more in the full profile.

07

Biomarkers

Visual assessment of escharWound bed vascularizationHydroxyproline release

Beyond the preview

Go deeper on Denatured and necrotic extracellular matrix and tissue proteins in burn eschar.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Denatured and necrotic extracellular matrix and tissue proteins in burn eschar.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call